Robin Doeswijk is Head of European Affairs at the European Hematology Association (EHA), which brings together and represents hematology professionals – including clinicians, diagnosticians and researchers – from across Europe and beyond.
With a background in International Relations (MA, University of Utrecht) and public affairs, Robin oversees EHA’s policy, advocacy and regulatory work as well as its partnerships and alliances. He is active on several committees and working groups of the BioMed Alliance, the European Cancer Organisation and Rare Cancers Europe and a member of the EMA HCP Policy Officers Group.
He represents EHA as well as the BioMed Alliance in discussions on the emerging EU HTA mechanism, viewed by EHA and its partners as an important step towards improving affordable and equal access to innovative therapies for patients throughout Europe.
Updated: February 2023